NeuExCell Therapeutics Inc. — Form D

NeuExCell Therapeutics Inc. of STATE COLLEGE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-23. $850K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2016-05-23
• Form: D
• Accession: 0001674966-16-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $850K
• Minimum investment: $50K
• Investors: 3
• Date of first sale: 2016-05-10
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-263642

Issuer

• Name: NeuExCell Therapeutics Inc.
• CIK: 0001674966
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2016
• Address: 2354 AUTUMNWOOD DR., STATE COLLEGE, PA, 16801
• Phone: 814-880-0367

Officers, directors & promoters (2)

More

• CIK 1674966 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search